A carregar...
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
In the past decade, advances in the use of monoclonal antibodies (mAbs) and adoptive cellular therapy to treat cancer by modulating the immune response have led to unprecedented responses in patients with advanced-stage tumours that would otherwise have been fatal. To date, three immune-checkpoint-b...
Na minha lista:
| Publicado no: | Nat Rev Clin Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5551685/ https://ncbi.nlm.nih.gov/pubmed/26977780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2016.25 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|